GCC Pharmaceutical Congress
03 May 2015 - 06 May 2015
Following last year’s success, the 2nd GCC Pharmaceutical Congress reinforces the importance of collaboration and dialogue amongst policy makers, stakeholders, regulators and pharmaceutical experts. The ultimate purpose of the congress is to drive the GCC pharmaceutical sector forward by sharing up-to-date information and highlighting key solutions. The congress will include presentations and interactive discussions that will cover key topics such as improving pharmacy practice, reviewing regulations and compliance as well as supporting excellence through continuous education programs.
The Address Dubai Marina, Dubai, UAE
http://www.gccpharmacongress.com/
GCC Medication Safety Congress
03 May 2015 - 06 May 2015
The GCC Medication Safety Congress will help bring back vital focus on the relevance of pharmacovigilance, identification and reporting of adverse events, medication reconciliation and many other measures in the pursuit of patient safety. The congress will familiarise attendees with the medication safety systems internationally and in the Gulf. Highlighting fundamentals of medication errors, the congress covers a variety of topics including improving medication safety infrastructure, medication reconciliation, psychotropic agent safety, expedited reporting, dealing with high alert medication and more. It will focus on promoting dialogue amongst regulators, medical professionals and pharmaceutical companies to ensure patient safety in the MENA region.
The Address Dubai Marina, Dubai, UAE
http://www.gccmedicationsafety.com/
Therapeutics Discovery Symposium USA - 2015 on RNAi, MicroRNAs and Stem Cells
04 May 2015 - 05 May 2015
SCOPE OF THE MEETING:
The purpose and scope of this Therapeutics Discovery Symposia USA - 2015 (on May 4-5, 2015) is to provide a forum for the discussion of the current state of the art of rapidly evolving RNA interference, MicroRNAs, Stem Cells and Regenerative Medicine highly interdisciplinary emerging fields in biotechnology. This will consists of two parallel theme meetings:
1.RNA interference & MicroRNAs-2015: This is our 12th international theme conference continuously held in the first week of May in Cambridge/Boston, Massachusetts, USA. Emeritus Professor Arthur Pardee of the Harvard University Medical School inaugurated our first meeting in May 2003. Since then, pioneers in both RNAi& MicroRNAs fields including: Nobel laureates Drs. Craig Mello, Richard Roberts and Professors Gary Ruvkun, David Bartel, Carlo Croce, and many more have given keynote speeches. RNAi and MicroRNAs are the “biology’s Big Bang” and we are igniting the spirit of both RNomicsµRNomics in order to understand the biology of gene-silencing and to develop innovative products based on this technology platform.
2. Stem Cells & Cell Signaling-2015: This is our 8th international theme conference continuously held in either West Coast or East Coast of USA. Nobel Laureate Paul Berg of the Stanford University Medical School inaugurated our first meeting in 2006. Since then, pioneers in both Stem Cells & Tissue Engineering fields including: Nobel Laureate Elizabeth Blackburn, John Gurdon, and Professors Gail Martin, Irving Weissman, Ole Issacson, Helen Blau, Kevin Eggan and many more have given keynote speeches. Stem cells have great utility not only in cell biology and clinically for treatment of diseases, but also in drug discovery and development. Therefore, this meeting will focus on developmental aspects to signaling mechanisms and genome-scale mapping of DNA methylation in pluripotency as well highlights the stem cell based-therapeutics from biotech industry and associated novel reagent/assay/tool developments from reagent companies.
Courtyard Marriott Hotel, Cambridge, MA USA
http://expressgenes.com/rnai2015/main.html
2nd Bioanalytic Sensors Conference
05 May 2015 - 06 May 2015
We invite you to the attend the 2nd Bioanalytic Sensors Conference, which will take place on May 5 - 6, 2015 in Berlin, Germany.
This premier conference will host an exciting group of professionals from the academic, biotech, pharmaceutical, and business communities, and will focus on the latest discoveries in the Bioanlytical Sensors field. A balance of both academic and industry experts will facilitate discussion on the following areas:
Sessions for the meeting include:
I. Advances in Sensor Development
II. Clinical Applications of Bioanalytical Sensors
III. Nano-material Enabled Sensing
IV. Disposable Sensors & Sensors for Low Resource Environments
V. Single Molecule Sensing
VI. In Vivo Sensing & Analysis
VII. Mass Spectometry and Immunosensing
VIII. Microfluidics
Radisson Blu Hotel, Berlin, Germany
https://www.gtcbio.com/conferences/bioanalytical-sensors-overview?utm_source=biosensors&utm_medium=eventlisting&utm_campaign=conferencelink
European Pharma Summit
05 May 2015 - 08 May 2015
This event seeks to create a forum for colleagues across multiple disciplines, as well as from both private and public sectors, to gather and exchange ideas. Over 400 delegates from pharmaceutical organization, biotech companies, and leading academic institutions will gather over the course of four days to listen to presentations on the hottest topics in drug discovery and network with both new and old colleagues.
The landscape for drug discovery has changed drastically over the past few years: private and public partnerships are changing how research is being done, researchers are using 3D model systems in hopes of improving clinical outcomes, and emerging target classes are changing traditional conceptions of the drug discovery process.
The Summit will feature six conferences that will cover the latest hot topics in drug discovery
Radisson Blu Hotel, Berlin, Germany
https://www.gtcbio.com/conferences/european-pharma-summit-overview
2nd Tissue Models & Drug Screening Conference
05 May 2015 - 06 May 2015
We invite you to the attend the 2nd Tissue Models & Drug Screening Conference, which will take place on May 5 - 6, 2015 in Berlin, Germany.
Over the years, three-dimensional (3D) models have become more favored over two-dimensional models (2D) because they better mimic the in vivo environment. Though 3D models have the potential to reduce failure in early stage drug discovery, there are still many questions to be answered: What are the gaps that still exist between 3D and 2D models? How will we conduct research to fill those gaps and what technological developments are needed?
Sessions for the meeting include:
I. Human Tissue Engineered Models for Drug Development
II. Deconvolving Targets of Hits from Phenotypic Screens
III. Phenotypic Screening with Functional Analysis Including Complex Models
IV. Biomimetic in Vitro Models: Development, Structure, and Function
V. In-Vivo 3D Models for Drug Safety Testing (toxicology) and Screening
This meeting will bring together researchers from across multiple disciplines, from both industry and academia, to discuss how we can better engineer tissues for clinical delivery and develop models for drug screening.
Radisson Blu Hotel, Berlin, Germany
https://www.gtcbio.com/conferences/tissue-models-drug-screening-overview
Phenotypic Screening Conference
07 May 2015 - 08 May 2015
We invite you to the attend the Phenotypic Screening Conference, which will take place on May 7 - 8, 2015 in Berlin, Germany.
Sessions for the meeting include:
I. Advances in Phenotypic Screening and Functional Analysis
II. Case Studies in Phenotypic Screening
III. High Content Analysis of Tumor Spheroid Models
IV. Phenotypic Screening Assay Development
V. Developing Physiologically Relevant Models: 3D, Tissue and Organ Systems (Higher Level Models)… (Tissue Model Joint Session)
VI. Target Identification & Target Fishing after a Phenotypic Screen
VII. Panel Discussion:
- Future Opportunities and Challenges for Phenotypic Screening
- The Role of Academic-industry Partnerships or Consortia to Advance Phenotypic Screening towards Improved Clinical Efficacy
Radisson Blu Hotel, Berlin, Germany
https://www.gtcbio.com/conferences/phenotypic-screening-overview
GCC Healthcare Innovation Congress
10 May 2015 - 13 May 2015
Innovation in healthcare continues to be a driving force in the pursuit to balance healthcare quality and cost. Innovation in healthcare is a critical component of business productivity and competitive survival. Through innovations, patients have better quality of life, better treatment options and increased life expectancy.
The Address Dubai Marina, Dubai, UAE
http://www.gcchealthcareinnovation.com/
Pharmacovigilance, Drug Safety & Risk Management
11 May 2015 - 12 May 2015
SMi Group are thrilled to announce the 4th annual conference, Pharmacovigilance, taking place on 11th & 12th May 2015 in Central London. Join us as we ask questions such as: How do we strengthen the link between a drug and its related adverse events from pre-clinical to post-marketing? What are the core and emerging challenges of adhering to Pharmacovigilance laws and risk management? Can we communicate benefits and risks to patients? How is the EudraVigilance system implemented in the pre and post-marketing approval of medicinal drugs? How can we harmonise coding for EU and US markets? PLUS MUCH MORE!
Holiday Inn Hotel, Regents Park, London, UK
http://www.smi-online.co.uk/goto/2015pharmacovigilance14.asp
Pain Therapeutics Conference
18 May 2015 - 19 May 2015
Returning for its 15th year SMi, are proud to present the UK’s premier event, the 15th Annual Pain Therapeutics Conference, 18th – 19th May 2015, London, UK. Through a series of interactive presentations and panel discussions, this event will give you access to key industry leaders, spotlighting principles and illustrative examples on current activities and trends in clinical and pre-clinical evidence-based and best-practice-based pain medicine. Highlighting research and developments in the field of pain relief this is an event that you will not want to miss!
Holiday Inn London Bloomsbury, London, UK
http://www.smi-online.co.uk/2015pain-therapeutics10.asp
ADC Summit 2015
18 May 2015 - 19 May 2015
Recent clinical successes have generated intense interest in ADC therapeutics. To develop ADCs that are more specific, more stable, and more effective; continued optimisation of the antibody, linker and payload of an ADC is critical. This conference goes to the heart of the technological challenges and asks: What does it take to develop superior ADCs and gain the clinical edge? Join us as we share, confer and debate how to create the next wave of ADCs with better efficacy, lower toxicity and improved potency for clinical success.
Holiday Inn Bloomsbury, London, UK
http://www.smi-online.co.uk/2015conjugates71.asp
Clinical Trial Logistics
20 May 2015 - 21 May 2015
The conference will focus on assessing the distribution and a risk based approach to develop and manage a coherent global supply chain. With a demand to assess and analyse the regulatory developments, this conference will focus on GCP, GMP and the qualification and validation of products through their life cycle. Attendees will gain understanding in the quality assurance aspect of the clinical trial logistics procedure in addition to the partnerships between CROs and discuss the hurdles that could be faced, alongside the opportunities that are arising.
Marriott Hotel, Regents Park, London, UK
http://www.smi-online.co.uk/2015ctlogistics7.asp
2nd Metabolomics - Advances & Applications in Human Disease Conference
21 May 2015 - 22 May 2015
There is still significant human variability in metabolite identification for targets and pathways. These challenges affect the advancement in metabolomics, the use of biomarkers, and its application towards cancer, metabolic disorders, and neurodegenerative diseases. Join us for an event that presents new research and offers networking opportunities with the researchers and scientists who are working on developing clinical assays, connecting the metabolome and the genome, and establishing common quality standards for experimental data.
Hyatt Regency, Boston, MA, USA
https://www.gtcbio.com/conferences/metabolomics-overview
Functional Genomics Conference
21 May 2015 - 22 May 2015
The Functional Genomics Conference focuses on understanding the specific cellular events that occur on every level of transcription, translation, and protein-protein interactions. Speakers will present on mutations that are controlled at the level of DNA and how they are predictors for the change in function and structure in downstream products. Recent developments in gene targeting technology provides crucial information in target validation for therapeutics and application in the areas of inflammation, oncology, immunology, and infectious diseases. Also, we will take a closer look at genomic variation in relation to predicting a patient's response to drugs.
Hyatt Regency, Boston, MA, USA
https://www.gtcbio.com/conferences/functional-genomics-overview
5th Next Generation Sequencing Conference
21 May 2015 - 22 May 2015
The 5th Next Generation Sequencing Conference will provide attendees with a better understanding of developments in new next generation sequencing technologies alongside clinical applications. Some key areas of research include nanopore sequencing, sequencing by tunneling, single cell RNA sequencing, all electron sequencing, and data integration.
Hyatt Regency, Boston, MA, USA
https://www.gtcbio.com/conferences/next-generation-sequencing-overview
Building Bridges in Translational Medicine
27 May 2015 - 28 May 2015
The ‘Building Bridges in Translational Medicine’ conference will examine how to reduce risk in projects through effective collaboration with industry, while leading industry experts will share viewpoints on industry-academia collaboration in public-private partnerships. National funding agencies and charities will attend in order to discuss resources and opportunities to optimise translation, reduce risk, and increase R&D productivity. Registration is free, but places are limited.
Zuiderkerk, Amsterdam, The Netherlands
http://www.eatris.eu/conference/